Stocks and Investing Stocks and Investing
Fri, October 16, 2020
Thu, October 15, 2020
Wed, October 14, 2020
Tue, October 13, 2020

Matthew Harrison Maintained (BIIB) at Buy with Decreased Target to $355 on, Oct 13th, 2020


Published on 2024-10-27 14:20:19 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $357 to $355 on, Oct 13th, 2020.

Matthew has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, September 18th, 2020
  • Carter Gould of "Barclays" Downgraded from Buy to Hold and Decreased Target to $280 on, Monday, June 22nd, 2020


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $342 on, Wednesday, August 19th, 2020
  • Brian Skorney of "Baird" Maintained at Sell with Decreased Target to $228 on, Friday, June 19th, 2020